Corvus Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
CRVS
CUSIP
221015100
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 105 36.3 M $115 M
2024 Q4 103 37.7 M $202 M
2024 Q3 74 30.1 M $159 M
2024 Q2 54 28.0 M $50.9 M
2024 Q1 55 18.5 M $32.9 M
2023 Q4 55 19.4 M $34.2 M
2023 Q3 57 19.2 M $28.0 M
2023 Q2 59 19.5 M $44.6 M
2023 Q1 39 20.8 M $18.9 M
2022 Q4 46 21.5 M $18.3 M
2022 Q3 49 22.1 M $18.1 M
2022 Q2 52 25.6 M $25.3 M
2022 Q1 66 27.4 M $44.9 M
2021 Q4 76 27.8 M $66.9 M
2021 Q3 77 28.2 M $136 M
2021 Q2 55 23.7 M $63.2 M
2021 Q1 53 20.4 M $62.8 M
2020 Q4 48 16.8 M $59.7 M
2020 Q3 42 17.2 M $69.0 M
2020 Q2 39 20.4 M $55.6 M
2020 Q1 45 20.7 M $43.6 M
2019 Q4 39 20.9 M $114 M
2019 Q3 36 22.9 M $68.9 M
2019 Q2 46 24.3 M $91.0 M
2019 Q1 59 24.8 M $99.5 M
2018 Q4 63 25.3 M $92.7 M
2018 Q3 65 25.7 M $220 M
2018 Q2 58 25.9 M $285 M
2018 Q1 56 25.4 M $289 M
2017 Q4 54 17.4 M $180 M
2017 Q3 54 17.5 M $280 M
2017 Q2 52 17.5 M $212 M
2017 Q1 53 17.3 M $360 M
2016 Q4 54 17.5 M $250 M
2016 Q3 45 16.3 M $268 M
2016 Q2 45 17.3 M $237 M
2016 Q1 32 16.4 M $228 M